[Pulmonary hypertension in pediatric and neonatal intensive care unit. Part I: Physiopathology]

E Dumas de la Roque1, L Storme, P Mauriat

  • 1Service de réanimation néonatale, CHU de Bordeaux, place Amélie-Raba-Léon, Bordeaux, France. edumasdlr@gmail.com

Insights

Pediatric and neonatal pulmonary hypertension presents significant management challenges, especially in critical care settings. This review explores its causes, physiology, and cardiopulmonary interactions.

Area of Science:

  • Pediatric critical care medicine
  • Neonatology
  • Cardiology

Context:

  • Pulmonary hypertension (PH) is a critical condition in pediatric and neonatal intensive care units (NICUs).
  • Management is complex, particularly in hemodynamically unstable patients.
  • PH is often linked to severe conditions like congenital heart disease, respiratory distress, and heart failure.

Purpose:

  • To review the pathogenesis and physiology of pulmonary hypertension in neonates and children.
  • To examine the cardiopulmonary interactions in pediatric and neonatal PH.
  • To discuss the adaptation to extra-uterine life in the context of PH.

Summary:

  • This review details the pathophysiology of pulmonary hypertension in critically ill neonates and children.
  • It covers the intricate cardiopulmonary dynamics and physiological adaptations relevant to this patient population.
  • Key associations, including congenital heart disease and respiratory distress, are highlighted.

Impact:

  • Provides critical insights for managing pediatric and neonatal pulmonary hypertension in intensive care settings.
  • Enhances understanding of the complex interplay between pulmonary and cardiac systems in PH.
  • Informs clinical practice and future research directions for improving outcomes in affected infants and children.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...